retatrutide clinical trials sign up for weight loss: Study shows 30% body weight loss Phase III retatrutide study demonstrates

I have more mental space to do other things instead of just thinking about, like, when Im going to eat again. It hasnt worked out well for everyone

FDA Communications The FDA publishes information about drug applications and approval timelines on its website

In September 2025, the agency issued over 50 warning letters to companies selling GLP-1 products (including retatrutide) with marketing that implied human use

Seven more large-scale trials (the TRIUMPH program, over 5,800 people total) are still running and will release results throughout 2026

You would need life-threatening complications from your weight, like severe heart failure or the inability to breathe properly

These trials are carefully monitored by medical professionals and regulatory agencies to ensure participant safety